Meeting
2018 ASCO Annual Meeting
Contrast enhancement as a prognostic factor in IDH1/2 mutant glioma.
Authors
Bogdana Suchorska
Department of Neurosurgery LMU, Munich, Germany
Bogdana Suchorska , Ulrich Schüller , Annamaria Biczok , Friedrich Wilhelm Kreth , Markus Lenski , Nathalie Lisa Albert , Armin Giese , Birgit Ertl-Wagner , Michael Ingrisch , Joerg Tonn
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Citation
J Clin Oncol 36, 2018 (suppl; abstr 2029)
DOI
10.1200/JCO.2018.36.15_suppl.2029
Abstract #
2029
Poster Bd #
187
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Characterizing malignant transformation in patients with IDH-mutant glioma.
First Author: Vicki Liu
Poster
2023 ASCO Breakthrough
A novel pathological finding, "BABA", for a prognostic factor in oral tongue carcinoma.
First Author: Daisuke Baba
Poster
2023 ASCO Genitourinary Cancers Symposium
Does body mass index matter in predicting renal mass sizes? Comparison of imaging modalities.
First Author: Young Son
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Tumour radiomics as imaging biomarker of tumour response to chemo-radiotherapy in patients with adenocarcinoma of rectum.
First Author: Reena Engineer